Trade ERNAW anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Ernexa Therapeutics Inc. Warrants (ERNAW) is trading at US$0.06, up 25.27% today as of Sep 4, 16:00 EDT. Over the past 52 weeks, ERNAW has traded between US$0.02 and US$0.23. On Syfe you can trade ERNAW with $0 commission and add it to your watchlist.
| Previous close | US$0.05 |
|---|---|
| 52-week range | US$0.02 – US$0.23 |
| Volume | 17.21K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Ernexa Therapeutics Inc. Warrants
Ernexa Therapeutics, Inc. engages in the research and development of cellular therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. Its pipeline includes ERNA-101 (Ovarian Cancer) and ERNA-201 (Rheumatoid Arthritis). The company was founded in 1984 and is headquartered in Cambridge, MA.
Year: 2026
Ernexa Therapeutics Inc. Warrants (ERNAW) stock is trading at US$0.06, +25.27% from the previous close of US$0.05.
The 52-week high for Ernexa Therapeutics Inc. Warrants (ERNAW) stock is US$0.23.
The 52-week low for Ernexa Therapeutics Inc. Warrants (ERNAW) stock is US$0.02.
Ernexa Therapeutics Inc. Warrants (ERNAW) does not currently pay a dividend.
Stay on top of ERNAW
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
